These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8947981)
1. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of an intravenous heparin nomogram in a coronary care unit. Paradiso-Hardy FL; Cheung B; Geerts WH Can J Cardiol; 1996 Sep; 12(9):802-8. PubMed ID: 8842133 [TBL] [Abstract][Full Text] [Related]
3. Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center. Balcezak TJ; Krumholz HM; Getnick GS; Vaccarino V; Lin ZQ; Cadman EC Am J Manag Care; 2000 Mar; 6(3):329-38. PubMed ID: 10977433 [TBL] [Abstract][Full Text] [Related]
4. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657 [TBL] [Abstract][Full Text] [Related]
5. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Kershaw B; White RH; Mungall D; Van Houten J; Brettfeld S Arch Intern Med; 1994 May; 154(9):1005-11. PubMed ID: 8179443 [TBL] [Abstract][Full Text] [Related]
6. Appropriate use of heparin. Empiric vs nomogram-based dosing. Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708 [TBL] [Abstract][Full Text] [Related]
7. The successful application of a heparin nomogram in a community hospital. Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069 [TBL] [Abstract][Full Text] [Related]
8. A standard heparin nomogram for the management of heparin therapy. Cruickshank MK; Levine MN; Hirsh J; Roberts R; Siguenza M Arch Intern Med; 1991 Feb; 151(2):333-7. PubMed ID: 1789820 [TBL] [Abstract][Full Text] [Related]
9. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457 [TBL] [Abstract][Full Text] [Related]
10. Rapid heparin anticoagulation: use of a weight-based nomogram. Schaefer DC; Hufnagle J; Williams L Am Fam Physician; 1996 Dec; 54(8):2517-21. PubMed ID: 8961850 [TBL] [Abstract][Full Text] [Related]
11. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity. Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569 [TBL] [Abstract][Full Text] [Related]
12. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction. Flaker GC; Bartolozzi J; Davis V; McCabe C; Cannon CP Arch Intern Med; 1994 Jul; 154(13):1492-6. PubMed ID: 8018004 [TBL] [Abstract][Full Text] [Related]
13. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224 [TBL] [Abstract][Full Text] [Related]
14. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia. Ansara AJ; Arif S; Warhurst RD Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826 [TBL] [Abstract][Full Text] [Related]
15. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline. Raschke RA; Gollihare B; Peirce JC Arch Intern Med; 1996 Aug 12-26; 156(15):1645-9. PubMed ID: 8694662 [TBL] [Abstract][Full Text] [Related]
16. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
17. Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome. Joncas SX; Poirier P; Ardilouze JL; Carrier N; Fayad T; Farand P Obesity (Silver Spring); 2013 Sep; 21(9):1753-8. PubMed ID: 23404940 [TBL] [Abstract][Full Text] [Related]
18. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature. Myzienski AE; Lutz MF; Smythe MA Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615 [TBL] [Abstract][Full Text] [Related]
19. Monitoring of unfractionated heparin using activated partial thromboplastin time: an assessment of the current nomogram and analysis according to age. Kim JS; Lee HJ; Sung JD; Kim HJ; Lee SY; Kim JS Clin Appl Thromb Hemost; 2014 Oct; 20(7):723-8. PubMed ID: 23615295 [TBL] [Abstract][Full Text] [Related]
20. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin. Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J; Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]